CNBC's Silvia Amaro looks at how investors around the world are digesting news of President Donald Trump's 100% tariff on branded drugs, and whether Europe's pharma giants will avoid the worst impact.
Silvia Amaro is a correspondent at CNBC, based in London. She specializes in European politics and financial markets, drawing on her extensive experience reporting from Brussels. Silvia's work has been featured in various prestigious outlets, including Flipboard, NBC News, and RealClearEnergy, and she was recognized as the CFA UK Broadcast Journalist of the Year in 2021 for her impactful reporting on economic inequality during the Covid-19 pandemic.












